Literature DB >> 14974424

The HIV Research Network: a unique opportunity for real time clinical utilization analysis in HIV.

Kelly A Gebo, Richard D Moore, John A Fleishman.   

Abstract

Mesh：

Year:  2003        PMID： 14974424

Source DB:  PubMed          Journal:  Hopkins HIV Rep        ISSN： 1551-8396


× No keyword cloud information.
  18 in total

1.  Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network.

Authors:  Allison L Agwu; John A Fleishman; P Todd Korthuis; George K Siberry; Jonathan M Ellen; Aditya H Gaur; Richard Rutstein; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2011-09-01       Impact factor: 3.731

2.  Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.

Authors:  Bethany L Morris; Callie A Scott; Timothy J Wilkin; Paul E Sax; Roy M Gulick; Kenneth A Freedberg; Bruce R Schackman
Journal:  HIV Clin Trials       Date:  2012 Jan-Feb

3.  Factors Associated With Retention Among Non-Perinatally HIV-Infected Youth in the HIV Research Network.

Authors:  Charles Farmer; Baligh R Yehia; John A Fleishman; Richard Rutstein; W Christopher Mathews; Ank Nijhawan; Richard D Moore; Kelly A Gebo; Allison L Agwu
Journal:  J Pediatric Infect Dis Soc       Date:  2014-10-19       Impact factor: 3.164

4.  Uptake and virological outcomes of single- versus multi-tablet antiretroviral regimens among treatment-naïve youth in the HIV Research Network.

Authors:  D C Griffith; C Farmer; K A Gebo; S A Berry; J Aberg; R D Moore; A H Gaur; W C Mathews; R Beil; P T Korthuis; A E Nijhawan; R M Rutstein; A L Agwu
Journal:  HIV Med       Date:  2018-12-18       Impact factor: 3.180

5.  Substance use and the quality of patient-provider communication in HIV clinics.

Authors:  P Todd Korthuis; Somnath Saha; Geetanjali Chander; Dennis McCarty; Richard D Moore; Jonathan A Cohn; Victoria L Sharp; Mary Catherine Beach
Journal:  AIDS Behav       Date:  2011-05

6.  Aging and loss to follow-up among youth living with human immunodeficiency virus in the HIV Research Network.

Authors:  Allison L Agwu; Lana Lee; John A Fleishman; Cindy Voss; Baligh R Yehia; Keri N Althoff; Richard Rutstein; W Christopher Mathews; Ank Nijhawan; Richard D Moore; Aditya H Gaur; Kelly A Gebo
Journal:  J Adolesc Health       Date:  2015-03       Impact factor: 5.012

7.  Patient activation and improved outcomes in HIV-infected patients.

Authors:  Rebecca Marshall; Mary Catherine Beach; Somnath Saha; Tomi Mori; Mark O Loveless; Judith H Hibbard; Jonathan A Cohn; Victoria L Sharp; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2013-05       Impact factor: 5.128

8.  Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Authors:  Elena Losina; Bruce R Schackman; Sara N Sadownik; Kelly A Gebo; Rochelle P Walensky; John J Chiosi; Milton C Weinstein; Perrin L Hicks; Wendy H Aaronson; Richard D Moore; A David Paltiel; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

9.  Alcohol use among HIV-infected persons in care: results of a multi-site survey.

Authors:  G Chander; J Josephs; J A Fleishman; P T Korthuis; P Gaist; J Hellinger; K Gebo
Journal:  HIV Med       Date:  2008-04       Impact factor: 3.180

10.  Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease.

Authors:  Bruce R Schackman; David W Haas; Jessica E Becker; Bethany K Berkowitz; Paul E Sax; Eric S Daar; Heather J Ribaudo; Kenneth A Freedberg
Journal:  Antivir Ther       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.